Phospho-MST1/MST2 (T180 + T183) Antibody [B24N16]

Catalog No.: F4812

Application: Reactivity: Human

Lane 1: Hela, Lane 2: Hela (Calyculin A treated)

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000-1:2000

Application
WB

Source
Rabbit Monoclonal Antibody

Reactivity
Human

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW Observed MW
56 kDa 59 kDa
^*なぜ予測分子量と実際の分子量が異なるのか？下記の原因により、実際の分子量が予測と異なる：タンパク質の翻訳後修飾（リン酸化/糖鎖付加），スプライシングバリアント，イソフォーム，相対的な電荷，ポリマー。

Datasheet & SDS

生物学的記述

Specificity
Phospho-MST1/MST2 (T180 + T183) Antibody [B24N16] detects endogenous levels of total MST1 and MST2 protein only when it is phosphorylated at T180 and T183, respectively.

Clone
B24N16

Synonym(s)
KRS1; MST2; STK3; Serine/threonine‑protein kinase 3; Mammalian STE20‑like protein kinase 2; STE20‑like kinase MST2; Serine/threonine‑protein kinase Krs‑1; MST‑2

Background
Phospho-MST1/MST2 (T180/T183) denotes the critical activation loop phosphorylation on the sterile-20-like kinases MST1 (STK4) and MST2 (STK3), core components of the Hippo signaling pathway that enforce organ size control through coordinated regulation of proliferation and apoptosis. These kinases feature conserved N-terminal catalytic domains with the T-loop motif and C-terminal regulatory segments harboring nuclear export signals and SAV1 docking sites. Activation occurs via autophosphorylation at T180/T183 following caspase-3/7 cleavage during apoptosis, which liberates the kinase domain from auto-inhibition, or through canonical Hippo signaling where Tao kinases prime MST1/2 oligomerization and trans-phosphorylation, enabling complex formation with SAV1 to phosphorylate and activate LATS1/2 kinases. The MST1/2-SAV1-LATS1/2 cassette then targets YAP/TAZ coactivators for inhibitory Ser127 phosphorylation, promoting their cytoplasmic retention via 14-3-3 binding and β-TRCP-mediated degradation, thereby silencing TEAD-dependent transcription of growth-promoting genes like CTGF and CYR61. This cascade integrates diverse inputs, including cell density via Merlin and adherens junctions, energy status through AMPK crosstalk, and mechanical cues, positioning phospho-T180/T183 as a proximal readout of Hippo flux that restrains tissue overgrowth while licensing apoptosis in damaged cells. It governs epithelial morphogenesis, liver regeneration, and stem cell quiescence, making it indispensable for researchers modeling tissue homeostasis in organoids or dissecting mechanotransduction via phospho-specific biosensors. Dysregulation through hypo-phosphorylation unleashes YAP/TAZ oncogenic activity in cancers like mesothelioma and hepatocellular carcinoma.

Background

Phospho-MST1/MST2 (T180/T183) denotes the critical activation loop phosphorylation on the sterile-20-like kinases MST1 (STK4) and MST2 (STK3), core components of the Hippo signaling pathway that enforce organ size control through coordinated regulation of proliferation and apoptosis. These kinases feature conserved N-terminal catalytic domains with the T-loop motif and C-terminal regulatory segments harboring nuclear export signals and SAV1 docking sites. Activation occurs via autophosphorylation at T180/T183 following caspase-3/7 cleavage during apoptosis, which liberates the kinase domain from auto-inhibition, or through canonical Hippo signaling where Tao kinases prime MST1/2 oligomerization and trans-phosphorylation, enabling complex formation with SAV1 to phosphorylate and activate LATS1/2 kinases. The MST1/2-SAV1-LATS1/2 cassette then targets YAP/TAZ coactivators for inhibitory Ser127 phosphorylation, promoting their cytoplasmic retention via 14-3-3 binding and β-TRCP-mediated degradation, thereby silencing TEAD-dependent transcription of growth-promoting genes like CTGF and CYR61. This cascade integrates diverse inputs, including cell density via Merlin and adherens junctions, energy status through AMPK crosstalk, and mechanical cues, positioning phospho-T180/T183 as a proximal readout of Hippo flux that restrains tissue overgrowth while licensing apoptosis in damaged cells. It governs epithelial morphogenesis, liver regeneration, and stem cell quiescence, making it indispensable for researchers modeling tissue homeostasis in organoids or dissecting mechanotransduction via phospho-specific biosensors. Dysregulation through hypo-phosphorylation unleashes YAP/TAZ oncogenic activity in cancers like mesothelioma and hepatocellular carcinoma.

References
[1] Bae SJ, et al. Biosci Rep. 2018 Aug 29;38(4):BSR20171469. [2] Zhou D, et al. Cancer Cell. 2009 Nov 6;16(5):425-38.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%